$STBA

HIEB WILLIAM J sold $887K of STBA

HIEB WILLIAM J sold 17,289 shares of S&T BANCORP INC (STBA) at an average of $51.31 ($51.18–$51.43, $0.89M total) across 27 trades over 2026-08-11 to 2026-08-12.

Original reporting
SEC EDGAR · HIEB WILLIAM J
Published Aug 13, 2026, 9:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 13, 2026, 10:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$STBA
Neutral
medium confidence
Mentioned
$STBA
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$STBANeutralLow
01

Why it matters

This is a primary-source insider sale event. It can influence short-term sentiment, but it does not introduce new company fundamentals or a discrete corporate action.

02

Market read

Traders may monitor for follow-on insider activity, but the filing alone is unlikely to drive a sustained repricing without additional fundamental catalysts.

03

What to watch

The article does not state whether other insiders sold/bought around the same window, nor does it provide context on compensation, option exercises, or prior sale patterns.

Relevance 5/10Novelty 5/10Timing: SEC Form 4 filed after-hours on 2026-08-13, covering sales on 2026-08-11 to 2026-08-12.

Background

The article is an SEC Form 4 insider transaction disclosure for S&T Bancorp, reported by a director.

Company-level read

Ticker impact

$STBANeutralMedium confidence
Context

S&T Bancorp director Hieb William J sold 17,289 shares in open-market trades totaling $887,075, with holdings after sale at 17,344 shares.

Expected impact

Near-term impact likely limited; any reaction should be modest unless follow-on selling or new fundamentals emerge.

Evidence & confidence

The filing is a primary SEC Form 4 disclosure, but it provides no earnings, guidance, deal, or regulatory development, and the transaction is described as open-market without a pre-arranged 10b5-1 plan.

Market effects

Insider selling in a regional bank can marginally affect sentiment toward bank governance/insider alignment, but no sector-wide signal is provided.

No explicit regional or peer linkage is described beyond the issuer-specific Form 4.

No global macro or cross-border linkage is mentioned.

Counterpoint

The absence of a 10b5-1 plan does not necessarily imply negative information; directors may sell for diversification, taxes, or liquidity needs.

Key entities

  • S&T Bancorp Inc

    Company whose director insider sale is disclosed on SEC Form 4.

  • Hieb William J

    Director who sold 17,289 shares in open-market transactions totaling $887,075.10.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$STBAMed

S&T Bancorp (STBA) Q3 2026 Earnings Call Transcript

S&T Bancorp (STBA) reported Q3 2026 earnings with net interest margin expanding to 4.06% and revenue growth outpacing expense growth. Loan balances were flat, but average loan and deposit balances increased. Tangible book value per share rose to $29.28. The company maintained strong asset quality and expects continued margin expansion with potential rate increases. They plan to upgrade their mobile banking platform in Q4 and anticipate flat to low single-digit loan growth.

$STBAMed

S&T Bancorp Q3 Earnings Call Highlights

S&T Bancorp reported Q3 2026 with revenue growth outpacing expenses, improving efficiency ratio to 54.65%. Loan growth was modest, with commercial real estate up $65M but commercial and industrial down $50M. Deposits saw seasonal decline, but asset quality remained strong. The company paused share buybacks and expects low-single-digit asset growth. Management emphasized underwriting discipline and inorganic growth opportunities.

$STBAMed

S&T Bancorp (STBA) stock is up, what you need to know

S&T Bancorp (STBA) shares rose 4.1% after reporting Q3 2026 earnings of $1.09 per share, beating estimates. Revenue was $107.79M, up from $106.72M expected. Net income increased to $38.6M. The company cited higher loan yields and share buybacks as contributors to the growth. CEO Chris McComish highlighted record earnings and revenue. Shares traded at $51, near the 52-week high of $53.36.

$STBAMed

S&T Bancorp’s (NASDAQ:STBA) Q3 2026 sales beat estimates

S&T Bancorp (STBA) reported Q3 2026 sales exceeding estimates, with net interest income comprising 87.6% of total revenue over five years. TBVPS grew at 7% annually over five years but slowed to 5.9% recently. EPS beat expectations, while net interest income narrowly outperformed estimates. TBVPS slightly missed forecasts. The stock price remained unchanged at $48.86 post-results.